SPARSH BIOTECH is rapidly establishing itself as a crucial player in the pharmaceutical sector, especially recognized for its advanced technique of creating Amoxycillin and Augmentin. The organization boasts sophisticated infrastructure and a focused team ensuring excellent antibiotics serving patients internationally. V